Neural Stem Cell Death Mechanisms Induced by Amyloid Beta

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) is characterized by amyloid plaques, primarily composed of amyloid beta (Aβ).
• The precise mechanisms of Aβ accumulation and initiation of AD pathogenesis at the cellular level remain incompletely understood.
• Previous research highlights Aβ's central role in AD, necessitating further investigation into its pathogenic pathways.

Purpose of the Study:

• To investigate the pathogenic mechanisms of amyloid beta (Aβ) in the central nervous system.
• To elucidate the effects of Aβ on neural stem cells (NSCs) using proteomics and antibody microarrays.
• To identify intracellular proteins associated with Aβ accumulation and its impact on cellular functions.

Main Methods:

• Primary cultured cortical neural stem cells (NSCs) were treated with varying concentrations of amyloid beta (Aβ).
• Cell viability was assessed using MTT assays, trypan blue staining, and bromodeoxyuridine proliferation assays.
• Proteomics and Western blotting were employed to detect and analyze intracellular proteins affected by Aβ treatment.

Main Results:

• Amyloid beta (Aβ) exposure decreased neural stem cell (NSC) viability and proliferation in a dose-dependent manner.
• Aβ treatment led to a significant reduction in key proteins including lactate dehydrogenase B, high-mobility group box 1, aldolase C, and Ezrin.
• Survival signaling pathways, such as phosphorylated phosphoinositide 3-kinase, Akt, and glycogen synthase kinase-3β, were diminished following Aβ exposure.

Conclusions:

• Proteomic and Western blot analyses identified several proteins and signaling pathways implicated in amyloid beta (Aβ) pathogenesis.
• The identified factors provide potential targets for understanding and potentially treating Alzheimer's disease.
• Further research is warranted to fully elucidate the roles of these factors in Aβ-induced neurotoxicity and AD progression.